Clinical Trial Update: A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA) [Phase 2]

View source ↗

Summary

Phase 2 study of MEMP1972A in patients with allergic asthma inadequately controlled on inhaled steroids and a second controller has completed. The sponsor is Ge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MEMP1972A

Snippet

Sponsor: Genentech, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED